Status:

RECRUITING

Evaluate the Effect of Atorvastatin on Cerebrovascular Reactivity in Mild Cognitive Impairment (MCI)

Lead Sponsor:

Johns Hopkins University

Collaborating Sponsors:

The Richman Family Precision Medicine Center of Excellence in Alzheimer Disease

Conditions:

Mild Cognitive Impairment

Eligibility:

All Genders

60-95 years

Phase:

PHASE2

Brief Summary

The purpose of this study is to evaluate the effect of atorvastatin on brain vessel reactivity and with it on blood flow in people with mild cognitive impairment.

Detailed Description

Participants are first being informed about potential benefits and risks of the study and are required to give written consent. After that participants will undergo detailed phone screen to determine ...

Eligibility Criteria

Inclusion

  • Inclusion Criteria are chosen to include participants with MCI, enriched for vascular risk factors:
  • MCI defined by Clinical Dementia Rating (CDR) of 0.5 or 1.0.
  • Memory, processing speed, executive function, language - cognitive scores \> 1.5 standard deviations below age-education norms.
  • Not demented by history.
  • Not taking statins currently or in the last 6 months.
  • Cognitive/functional impairment not likely due to another neurological disease or delirium.
  • Exclusion Criteria:
  • Taking a statin currently or have taken a statin in the last 6 months.
  • Contraindications to taking a statin.
  • Transplant patient taking cyclosporine.
  • Unable to undergo MRI procedures (such as having an implanted pacemaker or defibrillator or stimulator or having non MRI compatible metal).
  • Diagnosis of dementia by history.
  • Current diagnosis of substance abuse.
  • History of stroke or myocardial infarction in past 6 months.
  • History of HIV.

Exclusion

    Key Trial Info

    Start Date :

    May 21 2021

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 31 2026

    Estimated Enrollment :

    20 Patients enrolled

    Trial Details

    Trial ID

    NCT04765137

    Start Date

    May 21 2021

    End Date

    December 31 2026

    Last Update

    August 6 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Johns Hopkins University, Bayview Medical Center

    Baltimore, Maryland, United States, 21224